SlideShare a Scribd company logo
ANALYTICS OF COVID19 ON WORLD & INDIA
Dr. Abhishek Kumar
M.B.B.S.,M.D.E.M.S.,A.F.I.H.,C.C.D.M.,D. Diabetology
What is the need of analytic study?
What is the need of analytic study?
 The aim is to answer several open questions:
1. How does COVID-19 spread around the world?
2. What is its impact in terms of confirmed and death
cases at the continent, region, and country levels?
3. How does its severity compare with other epidemic
outbreaks, including Ebola 2014,MERS 2012, and
SARS 2003?
4. Is there a correlation between the number of
confirmed cases and death cases?
This presentation presents a comprehensive analytics
visualization to address the questions mentioned above.
How does COVID-19 spread around the world :-
 The Coronavirus (COVID-19) outbreak nowadays represents the
most critical event worldwide.
 It has been declared by the World Health Organization (WHO)
as a Global Public Health Emergency
 By the end of January 2020, and then as a Global Pandemic in
March 2020.
 The virus has begun on from Wuhan district in China , where the
first confirmed case was reported to have happened on
November 17, 2020 .
 Initially, the confirmed cases in China were continually
increasing.
 On January 31, the total infections reached a bit less than 10000
confirmed cases, with214 recovered and 213 reported deaths (2%
death rate, and similar for recovery).
 One of the most dangerous aspects of the Coronavirus is that it has an
incubation period of 2-14 days, during which the patient transmits the
virus without having any symptoms.
 All these circumstances have favored the exponential growth of the
infection leading to a world health emergency crisis.
 A total of 173 countries are reported to have confirmed cases with
different gravity, while only 60 countries had confirmed cases at the
end of February 2020, and only 25 countries at the end of January 2020.
 This means that the increase rate was between 2.4 to 2.9 each month.
 As a consequence, after only two months from the official declaration
of COVID-19 as Global Public Health Emergency, and despite the
numerous exceptional preventive measures that every country has
taken to avoid the outbreak, the virus has contaminated almost all the
world countries.
 We compare the impact of the COVID-19 virus with the previous and
recent epidemic diseases that have emerged in the last 20 years, namely
Ebola 2014, Middle East Respiratory Syndrome (MERS 2012), and
Severe Acute Respiratory Syndrome (SARS 2003) outbreaks.
World wide spread of COVID-19.
Observed from the figure that the outbreak pick growth started towards the end of February, which is almost four weeks since the
disease was declared as a Global Public Health Emergency.
WORLD COVID-19 DATA dated 23/4/20
TOTAL COVID CASES
 Coronavirus Cases: 2,638,909
 Deaths:184,249
 Recovered:722,055
ACTIVE CASES:1,732,605
 Currently Infected Patients
 1,674,327 (97%)in Mild Condition
 58,278 (3%)Serious or Critical
CLOSED CASES: 906,304
 Cases which had an outcome:
 722,055 (80%)Recovered / Discharged
 184,249 (20%)Deaths
How does COVID-19 evolve and its impact:-
COVID-19 DATA FOR LAST 3 MONTHS :
Cumulative Cases/Day January 2020 February 2020 March 2020
Confirmed Case Rate 1071 2730 16679
Death Cases 22 103 792
Recovered Cases 19 1373 2906
Active Cases 1029 1252 12890
 The global cumulative confirmed case rates are 2.54 times higher in
February 2020, and 15.67 times higher in March 2020, as compared to the
confirmed case rate of January 2020.
COVID-19 Dashboard 1: The four figures in the first row presents the cumulative confirmed, recovered, death
and active cases from January 22,2020 to March 27, 2020.
INTERPRETATION:
 The global cumulative recovered case rates are 72.26 times higher in February
2020, and 152 times higher in March 2020, as compared to the recovered case rate of
January 2020. This indicates the reduction in the severe and increasing fatality
impact of the COVID-19.
This is a good indication that, with the increase in the number of cases, there is a better
understanding of the disease and containment.
 The global cumulative death case rates are 4.68 times higher in February 2020,
and 36 times higher in March 2020, as compared to the death case rate of
January2020. This indicates the severe and increasing fatality impact of the COVID-
19.
Death rates in February were stationary at an average of 92 deaths per day. However, in
March 2020, the death rates had a factor of 108.
 Comparing the trend death and the trend of recovered cases, it can be
observed that the ratio of recovered to death rates, was 0.86 (19/22) in January
2020,meaning that the death rate was a bit higher .However, in February 2020, the
ratio of recovered to death rates increases to 13.33 (1373/103) and reaches 3.66
(2906/792) in March 2020.
The general trend is that the disease is being more controlled in terms of fatality rates
due to increasing emergency procedures that the different countries have
implemented.
 It has been observe that in the top-10 countries, there are six countries
are from Europe (i.e., Italy, Spain, Germany, France, United Kingdom,
and Switzerland), three from Asia (China, Iran and South Korea), and
the United States of America, which recently become top-1 in terms of
the number of infections.
 Nonetheless, the highest death rate is in Italy, with more than 9000
death cases reported, because Italy has been severely affected by the
virus well before the USA, since the end of February. However, the USA
is currently having a death rate of 39 deaths per day, whereas it has 0
deaths in February 2020.
 Based on the data collected there is a strongly believed that the
COVID-19 takes almost one month to transit from one continent to
another in the direction from the East to the West since the pick was in
China at the end of January, then it was in Italy (South of Europe) at
the end of February, and it reached the USA at the end of March, where
the pick of infection are in New York located at the Eastern side of the
USA.
 The Eastern side of the USA, and mainly New York, are the most
affected considering that it is closer to Europe. If the trend is the same,
it will be expected that the West side of the USA will reach its pick by
the end of April 2020.
How does COVID-19 compare to other epidemics?
 It is visually apparent that COVID-19 is the largest outbreak to a considerable extent,
followed by SAR 2003, then Ebola 2012, and finally, MERS 2001.
 In what concerns the number of infected countries, COVID-19 has reached 177
countries, then SARS 2003 reached 36 countries, then MERS 2012 has affected 27
countries, and Ebola 2014 was spread in 10 countries. The severity and acuteness of
COVID-19 are unprecedented.
 Ebola 2014 has spanned over a significant period from August 2014 until March 2016,
it reached only 15249 confirmed cases. Thus it had an infection rate minimal as
compared to the two other diseases. Most of the confirmed cases were concentrated
in the Western coast of Africa, where the disease has emerged.
 SARS 2003 had a lifetime of five months from March 2003 until July 2003 and
reached 8434 confirmed cases with an average of 1686 cases per month, and a pick
rate in April 2003, one month after the outbreak.
 It can be observed that COVID-19 is considered as a more acute specie of SARS 2003,
as they both share some common features, including: (1) both have started from
China, (2)they belong to the same family of Coronavirus syndrome affecting the
respiratory system, (3) they have the highest contamination rate as compared to other
epidemics.
 Based on these observations, it seems that the COVID-19 containment will take a
more extended period for its complete containment as compared to SARS 2003.
Impact in terms of confirmed and death cases at the
continent, region, and country levels:-
We can conclude that theCOVID-19 is exceptionally more aggressive
in terms of confirmed cases with more than 90% of the share of the
heat map, where it is at around 80% concerning the fatality impact.
The remaining 10% of confirmed cases and 20% of death cases are
shared between Ebola 2014 and SARS 2003.
 At continent-level, Europe is the most affected with COVID-19
with 51.64% of confirmed cases, then Asia with 23.92%, and the
Americas with 19.02%. The impact of Ebola on Africa is only
2.46%, and the impact of SARS 2003 on Asia is only 1.26 %.
 At region-level, the Southern Europe region has 25.94% of
confirmed cases, followed by Western Europe Asia 19.8%, then
Northern America 17.19%, and Eastern Asia with 15%. The impact
of Ebola 2014 on Western Africa is valued to 2.46%, and the
impact of SARS Eastern Asia is only 1.26%.
At the country-level, The USA has the most significant share of confirmed cases (as of
March 27, 2020) with 16.43%, followed by Italy 13.98%, then China 13.15%. We can also
observe that the number of confirmed cases of Ebola 2014 in Sierra Leon is similar to the
COVID-19 spread in South Korea and countries in the West of Europe, namely,
Netherlands, Belgium, and Austria.
 Regarding the death cases’ impact, it is different from the confirmed cases.
At continent-level, the highest death impact is in Europe with 56.26%, then Asia with
18.56% with COVID-19, which is of the same magnitude as the fatality of Ebola 2014 in
Africa.
 The highest average of confirmed cases per continent is in Europe, with 4992 deaths of
COVID-19, and the second-highest average confirmed cases per continent is 1906
deaths in Africa with Ebola 2014. MERS and SARS have the same average confirmed
cases. Regarding the average deaths per continent, Ebola 2014 comes in the first place
with 947 deaths per country in Africa on average followed by COVID-19, with 296
deaths in each European country on average. SARS 2003 only affected 55 deaths per
country in Asia on average.
MEDIAN AGE PER CONTINENT
INDIA COVID-19 DATA dated 23/4/20
 Confirmed: 21,455
 Active: 16,391
 Recovered: 4,382
 Deceased: 682
The first case in India was reported on 30th January 2020. Also, a single case can infect
1.5 more individuals of the population. Epidemic doubling time is estimated to be
around 4.1 days
State/UT Confirmed Active Recovered Deceased
Maharashtra 5,649 4,591 789 269
Gujarat 2,407 2,125 179 103
Delhi 2,248 1,476 724 48
Rajasthan 1,935 1,564 344 27
Tamil Nadu 1,629 949 662 18
Madhya Pradesh 1,587 1,355 152 80
Uttar Pradesh 1,449 1,255 173 21
Telangana 943 725 194 24
Andhra Pradesh 813 669 120 24
West Bengal 456 362 679 15
Kerala 437 127 308 2
Karnataka 427 279 131 17
Jammu and Kashmir 407 310 92 5
Punjab 278 209 53 16
Haryana 264 103 158 3
Bihar 143 99 42 2
Odisha 83 50 32 1
Jharkhand 49 38 48 13
Uttarakhand 46 23 23 -
Himachal Pradesh 39 21 16 2
Chhattisgarh 36 8 28 -
Assam 35 15 19 1
Chandigarh 27 13 14 -
Andaman and Nicobar Islands 18 7 11 -
Ladakh 18 2 216 -
Meghalaya 12 11 - 1
Goa 7 - 7 -
Puducherry 7 3 4 -
Manipur 2 - 2 -
Tripura 2 1 1 -
Arunachal Pradesh 1 - 1 -
Mizoram 1 1 - -
Total 8321,455 16,391 124,382 1682
The COVID19 Hot-Spot Map of India]
Challenges in front of India:
• AVERAGE HEALTH CARE
SYSYTEM
• ILLITERACY
• POVERTY
• IGNORANCE
• UNEMPLOYEMENT
• MIGRATION
Age Wise COVID-19 Patients:
We can notice that the 21-60 years group constitute for 77% of the total patients.
0-30 years constitutes to 30% of the total patients and this is significant as this
group falls into a “super-spreader” category.
Individual States vs National average of age-wise
break up of COVID19 patients
Delhi has a very high proportion of patients in the 21-30 years age bucket.
Uttar Pradesh has a high proportion of patients in the 31-40 years age bucket.
In Rajasthan, it is a case of the elderly getting infected more as they have a lot
of patients in the 61-70 years age bracket. Telangana like Delhi has more
patients in the 21-30 years age bracket.
For the 21-30 years age bracket, more social media messaging would help.
RECOVERY PERIOD OF PATIENTS
Illustrated 36% of patients get discharged within 10 days, 43% within 20 days and the
rest within a month from being confirmed positive. This data can help governments to
better equip hospital beds or ventilators IF we see high exponential rise of cases in
India. It can also be used to assess the severity of the cases and the effects of the
treatment meted out to patients.
Sex wise COVID-19 Patients:
Men do continue to lead the charts. This is in line with the global numbers, where
2/3rd of the infected are men.
In India, 69% of the infections involve men and the rest are female.
IMPORTED VS LOCAL
As of now, we have 73% local cases and 27% imported cases. The biggest
contributor to the local cases was of course the #Tablighi Jamaat cluster.
Breakup of foreigners tested +ve in
India
We have a host of Italian and Indonesian citizens who has tested positive in India
along with UK citizens. The Jamaat cluster gave rise to a lot of Indonesian, Malaysian
and Thai nationals testing positive for COVID-19.
What’s in future India?
 The coronavirus pandemic in India may peak in early to mid-May, according to
projections in a study conducted by global consulting firm Protiviti and Times
Network. The study predicts the number of cases will range from 30,000 to a
worst-case scenario of about 286,000. About 30% of the affected people may
require intensive care facilities.
 Susceptible Exposed Infected Recovered (SEIR)model suggests the pandemic
may continue on a nationwide scale until August end. Some states may come out
of the crisis by late May or early June while states with a higher number of
infected people may take up to a month longer.
 The Covid-19 pandemic is causing deep economic harm and could reverse the
gains made in the industrial economy over many decades. There is a need to
render immediate and sizable support to industry to protect people, jobs and
enterprises."
 Oxford University will start human testing with a
Covid-19 vaccine they developed from Thursday, the
UK government said in a coronavirus press conference.
 The Oxford team – led by Professor Sarah Gilbert, is
testing ChAdOx1 nCoV-19, a candidate based on a
chimpanzee adenovirus modified to include the spike
or ‘S’ protein on the surface of SARS-CoV-2, the virus
that causes Covid-19.

More Related Content

What's hot

Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical TrialsOutcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
Guy Boulianne
 
COVID19 - CONSUMERBEHAVIORIMPACT - AFRICA
COVID19 - CONSUMERBEHAVIORIMPACT  - AFRICACOVID19 - CONSUMERBEHAVIORIMPACT  - AFRICA
COVID19 - CONSUMERBEHAVIORIMPACT - AFRICA
MEDx eHealthCenter
 
The Spartacus Letter – Rev. 2 (2021-09-28) | Spartacus
The Spartacus Letter – Rev. 2 (2021-09-28) | SpartacusThe Spartacus Letter – Rev. 2 (2021-09-28) | Spartacus
The Spartacus Letter – Rev. 2 (2021-09-28) | Spartacus
Guy Boulianne
 
Pneumonia and diarrhoea: tackling the deadliest diseases for the world’s poor...
Pneumonia and diarrhoea: tackling the deadliest diseases for the world’s poor...Pneumonia and diarrhoea: tackling the deadliest diseases for the world’s poor...
Pneumonia and diarrhoea: tackling the deadliest diseases for the world’s poor...
UNICEF Publications
 
The Vaccine Death Report
The Vaccine Death ReportThe Vaccine Death Report
The Vaccine Death Report
Guy Boulianne
 
Nazi concentration camp survivors letter to ICC 20.9.2021
Nazi concentration camp survivors letter to ICC 20.9.2021Nazi concentration camp survivors letter to ICC 20.9.2021
Nazi concentration camp survivors letter to ICC 20.9.2021
Guy Boulianne
 
2020 09 01 Vaccination
2020 09 01 Vaccination2020 09 01 Vaccination
2020 09 01 Vaccination
MMI66 / MAG Market Intelligence
 
Programme Methodist Womens Federation day-2020
Programme Methodist Womens Federation day-2020Programme Methodist Womens Federation day-2020
Programme Methodist Womens Federation day-2020
ApenisaSeru2
 
Assessing Differential Impacts of COVID-19 on African Countries: A Comparativ...
Assessing Differential Impacts of COVID-19 on African Countries: A Comparativ...Assessing Differential Impacts of COVID-19 on African Countries: A Comparativ...
Assessing Differential Impacts of COVID-19 on African Countries: A Comparativ...
oyepata
 
Coronavirus (COVID-19) SLIDE
Coronavirus (COVID-19) SLIDECoronavirus (COVID-19) SLIDE
Coronavirus (COVID-19) SLIDE
BhagyeshTrivedi3
 
Sub-Saharan African healthcare. The user experience
Sub-Saharan African healthcare. The user experienceSub-Saharan African healthcare. The user experience
Sub-Saharan African healthcare. The user experience
The Economist Media Businesses
 
Yale ESF-8 Special Report COVID-19 3-26-2020
Yale ESF-8 Special Report COVID-19 3-26-2020Yale ESF-8 Special Report COVID-19 3-26-2020
Yale ESF-8 Special Report COVID-19 3-26-2020
Yale -Tulane ESF-8 Planning and Response Network
 
Yale-Tulane-Sacred Heart- ESF-8 Special Global Report - COVID-19 4-27-20
Yale-Tulane-Sacred Heart- ESF-8 Special  Global Report - COVID-19 4-27-20 Yale-Tulane-Sacred Heart- ESF-8 Special  Global Report - COVID-19 4-27-20
Yale-Tulane-Sacred Heart- ESF-8 Special Global Report - COVID-19 4-27-20
Yale -Tulane ESF-8 Planning and Response Network
 
Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19 5-1-20
Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19  5-1-20Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19  5-1-20
Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19 5-1-20
Yale -Tulane ESF-8 Planning and Response Network
 
COVID-19 and Italy: what next?
COVID-19 and Italy: what next?COVID-19 and Italy: what next?
COVID-19 and Italy: what next?
Valentina Corona
 
Ramadan and Covid-19 Pandemic: Lessons for the Ummah
Ramadan and Covid-19 Pandemic: Lessons for the Ummah Ramadan and Covid-19 Pandemic: Lessons for the Ummah
Ramadan and Covid-19 Pandemic: Lessons for the Ummah
Yusuf Suleiman, PhD
 
Coronavirus Pandemic Part II: Public Policies & Impact
Coronavirus Pandemic Part II: Public Policies & ImpactCoronavirus Pandemic Part II: Public Policies & Impact
Coronavirus Pandemic Part II: Public Policies & Impact
Kumaraguru Veerasamy
 
Yale - Tulane - Sacred Heart ESF-8 US Special Report - COVID-19 Nursing Hom...
Yale - Tulane - Sacred Heart  ESF-8 US Special Report  - COVID-19 Nursing Hom...Yale - Tulane - Sacred Heart  ESF-8 US Special Report  - COVID-19 Nursing Hom...
Yale - Tulane - Sacred Heart ESF-8 US Special Report - COVID-19 Nursing Hom...
Yale -Tulane ESF-8 Planning and Response Network
 

What's hot (20)

Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical TrialsOutcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
 
3.1 francois dabis
3.1 francois dabis3.1 francois dabis
3.1 francois dabis
 
COVID19 - CONSUMERBEHAVIORIMPACT - AFRICA
COVID19 - CONSUMERBEHAVIORIMPACT  - AFRICACOVID19 - CONSUMERBEHAVIORIMPACT  - AFRICA
COVID19 - CONSUMERBEHAVIORIMPACT - AFRICA
 
Developing final
Developing finalDeveloping final
Developing final
 
The Spartacus Letter – Rev. 2 (2021-09-28) | Spartacus
The Spartacus Letter – Rev. 2 (2021-09-28) | SpartacusThe Spartacus Letter – Rev. 2 (2021-09-28) | Spartacus
The Spartacus Letter – Rev. 2 (2021-09-28) | Spartacus
 
Pneumonia and diarrhoea: tackling the deadliest diseases for the world’s poor...
Pneumonia and diarrhoea: tackling the deadliest diseases for the world’s poor...Pneumonia and diarrhoea: tackling the deadliest diseases for the world’s poor...
Pneumonia and diarrhoea: tackling the deadliest diseases for the world’s poor...
 
The Vaccine Death Report
The Vaccine Death ReportThe Vaccine Death Report
The Vaccine Death Report
 
Nazi concentration camp survivors letter to ICC 20.9.2021
Nazi concentration camp survivors letter to ICC 20.9.2021Nazi concentration camp survivors letter to ICC 20.9.2021
Nazi concentration camp survivors letter to ICC 20.9.2021
 
2020 09 01 Vaccination
2020 09 01 Vaccination2020 09 01 Vaccination
2020 09 01 Vaccination
 
Programme Methodist Womens Federation day-2020
Programme Methodist Womens Federation day-2020Programme Methodist Womens Federation day-2020
Programme Methodist Womens Federation day-2020
 
Assessing Differential Impacts of COVID-19 on African Countries: A Comparativ...
Assessing Differential Impacts of COVID-19 on African Countries: A Comparativ...Assessing Differential Impacts of COVID-19 on African Countries: A Comparativ...
Assessing Differential Impacts of COVID-19 on African Countries: A Comparativ...
 
Coronavirus (COVID-19) SLIDE
Coronavirus (COVID-19) SLIDECoronavirus (COVID-19) SLIDE
Coronavirus (COVID-19) SLIDE
 
Sub-Saharan African healthcare. The user experience
Sub-Saharan African healthcare. The user experienceSub-Saharan African healthcare. The user experience
Sub-Saharan African healthcare. The user experience
 
Yale ESF-8 Special Report COVID-19 3-26-2020
Yale ESF-8 Special Report COVID-19 3-26-2020Yale ESF-8 Special Report COVID-19 3-26-2020
Yale ESF-8 Special Report COVID-19 3-26-2020
 
Yale-Tulane-Sacred Heart- ESF-8 Special Global Report - COVID-19 4-27-20
Yale-Tulane-Sacred Heart- ESF-8 Special  Global Report - COVID-19 4-27-20 Yale-Tulane-Sacred Heart- ESF-8 Special  Global Report - COVID-19 4-27-20
Yale-Tulane-Sacred Heart- ESF-8 Special Global Report - COVID-19 4-27-20
 
Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19 5-1-20
Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19  5-1-20Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19  5-1-20
Yale- Tulane-Sacred Heart ESF-8 Special US Report - COVID-19 5-1-20
 
COVID-19 and Italy: what next?
COVID-19 and Italy: what next?COVID-19 and Italy: what next?
COVID-19 and Italy: what next?
 
Ramadan and Covid-19 Pandemic: Lessons for the Ummah
Ramadan and Covid-19 Pandemic: Lessons for the Ummah Ramadan and Covid-19 Pandemic: Lessons for the Ummah
Ramadan and Covid-19 Pandemic: Lessons for the Ummah
 
Coronavirus Pandemic Part II: Public Policies & Impact
Coronavirus Pandemic Part II: Public Policies & ImpactCoronavirus Pandemic Part II: Public Policies & Impact
Coronavirus Pandemic Part II: Public Policies & Impact
 
Yale - Tulane - Sacred Heart ESF-8 US Special Report - COVID-19 Nursing Hom...
Yale - Tulane - Sacred Heart  ESF-8 US Special Report  - COVID-19 Nursing Hom...Yale - Tulane - Sacred Heart  ESF-8 US Special Report  - COVID-19 Nursing Hom...
Yale - Tulane - Sacred Heart ESF-8 US Special Report - COVID-19 Nursing Hom...
 

Similar to Analytics on covid 19

Forecasting the peak and fading out of novel coronavirus of 2019
Forecasting the peak and fading out of novel coronavirus of 2019Forecasting the peak and fading out of novel coronavirus of 2019
Forecasting the peak and fading out of novel coronavirus of 2019
Islam Saeed
 
Cidrap covid19-viewpoint-part1
Cidrap covid19-viewpoint-part1Cidrap covid19-viewpoint-part1
Cidrap covid19-viewpoint-part1
LanaSokoljva
 
Emergency management .docx
Emergency management                                              .docxEmergency management                                              .docx
Emergency management .docx
christinemaritza
 
Fact and Opinion about Covid-19 outbreak
Fact and Opinion about Covid-19 outbreakFact and Opinion about Covid-19 outbreak
Fact and Opinion about Covid-19 outbreak
NoviaNatalia1
 
Global Impacts and Nigeria Responsiveness to the COVID-19 Pandemic
Global Impacts and Nigeria Responsiveness to the COVID-19 PandemicGlobal Impacts and Nigeria Responsiveness to the COVID-19 Pandemic
Global Impacts and Nigeria Responsiveness to the COVID-19 Pandemic
Healthcare and Medical Sciences
 
Covid 19 Coronavirus - facts and figures
Covid 19 Coronavirus - facts and figuresCovid 19 Coronavirus - facts and figures
Covid 19 Coronavirus - facts and figures
JanMstel
 
A Review of Coronavirus Disease-2019 IJPSCR
A Review of Coronavirus Disease-2019  IJPSCRA Review of Coronavirus Disease-2019  IJPSCR
A Review of Coronavirus Disease-2019 IJPSCR
BRNSSPublicationHubI
 
Covid 19 is now a pandemic
Covid 19 is now a pandemicCovid 19 is now a pandemic
Covid 19 is now a pandemic
Ronald Vincent
 
Abstract Covid-19
Abstract Covid-19Abstract Covid-19
Abstract Covid-19
haseebgg
 
Precationary measures toavoid covid 19
Precationary measures toavoid covid 19Precationary measures toavoid covid 19
Precationary measures toavoid covid 19
Ghulam Abbas Hashmi
 
Ruan2020 likelihood of survival of coronavirus disease 2019
Ruan2020   likelihood of survival of coronavirus disease 2019Ruan2020   likelihood of survival of coronavirus disease 2019
Ruan2020 likelihood of survival of coronavirus disease 2019
Nilda Vllacres
 
Presentation on COVID-19 in March 2020
Presentation on COVID-19 in March 2020Presentation on COVID-19 in March 2020
Presentation on COVID-19 in March 2020
Tehmas Ahmad
 
Fact and opinion about covid 19 outbreak
Fact and opinion about covid 19 outbreakFact and opinion about covid 19 outbreak
Fact and opinion about covid 19 outbreak
Titania Delfiano
 
The second wave covid -19
The second wave covid -19The second wave covid -19
The second wave covid -19
Dr Issah J.K
 
COVID 19 meta analysis - DIG- April-28-2020
COVID 19 meta analysis - DIG- April-28-2020COVID 19 meta analysis - DIG- April-28-2020
COVID 19 meta analysis - DIG- April-28-2020
Andrew MacPherson
 
Case study of covid 19.pdf by HARSHITHA BHARADWAJ
Case study of covid 19.pdf by HARSHITHA BHARADWAJCase study of covid 19.pdf by HARSHITHA BHARADWAJ
Case study of covid 19.pdf by HARSHITHA BHARADWAJ
prem kamal
 
Abstract congress covid 19.docx30
Abstract congress covid 19.docx30Abstract congress covid 19.docx30
Abstract congress covid 19.docx30
Enida Xhaferi
 
covoid 19.pptx
covoid 19.pptxcovoid 19.pptx
covoid 19.pptx
saad510479
 
Corona Virus
Corona VirusCorona Virus
Corona Virus
Zia ullah
 
Similarities and Differences between the New Coronavirus Infectious 2019 COVI...
Similarities and Differences between the New Coronavirus Infectious 2019 COVI...Similarities and Differences between the New Coronavirus Infectious 2019 COVI...
Similarities and Differences between the New Coronavirus Infectious 2019 COVI...
ijtsrd
 

Similar to Analytics on covid 19 (20)

Forecasting the peak and fading out of novel coronavirus of 2019
Forecasting the peak and fading out of novel coronavirus of 2019Forecasting the peak and fading out of novel coronavirus of 2019
Forecasting the peak and fading out of novel coronavirus of 2019
 
Cidrap covid19-viewpoint-part1
Cidrap covid19-viewpoint-part1Cidrap covid19-viewpoint-part1
Cidrap covid19-viewpoint-part1
 
Emergency management .docx
Emergency management                                              .docxEmergency management                                              .docx
Emergency management .docx
 
Fact and Opinion about Covid-19 outbreak
Fact and Opinion about Covid-19 outbreakFact and Opinion about Covid-19 outbreak
Fact and Opinion about Covid-19 outbreak
 
Global Impacts and Nigeria Responsiveness to the COVID-19 Pandemic
Global Impacts and Nigeria Responsiveness to the COVID-19 PandemicGlobal Impacts and Nigeria Responsiveness to the COVID-19 Pandemic
Global Impacts and Nigeria Responsiveness to the COVID-19 Pandemic
 
Covid 19 Coronavirus - facts and figures
Covid 19 Coronavirus - facts and figuresCovid 19 Coronavirus - facts and figures
Covid 19 Coronavirus - facts and figures
 
A Review of Coronavirus Disease-2019 IJPSCR
A Review of Coronavirus Disease-2019  IJPSCRA Review of Coronavirus Disease-2019  IJPSCR
A Review of Coronavirus Disease-2019 IJPSCR
 
Covid 19 is now a pandemic
Covid 19 is now a pandemicCovid 19 is now a pandemic
Covid 19 is now a pandemic
 
Abstract Covid-19
Abstract Covid-19Abstract Covid-19
Abstract Covid-19
 
Precationary measures toavoid covid 19
Precationary measures toavoid covid 19Precationary measures toavoid covid 19
Precationary measures toavoid covid 19
 
Ruan2020 likelihood of survival of coronavirus disease 2019
Ruan2020   likelihood of survival of coronavirus disease 2019Ruan2020   likelihood of survival of coronavirus disease 2019
Ruan2020 likelihood of survival of coronavirus disease 2019
 
Presentation on COVID-19 in March 2020
Presentation on COVID-19 in March 2020Presentation on COVID-19 in March 2020
Presentation on COVID-19 in March 2020
 
Fact and opinion about covid 19 outbreak
Fact and opinion about covid 19 outbreakFact and opinion about covid 19 outbreak
Fact and opinion about covid 19 outbreak
 
The second wave covid -19
The second wave covid -19The second wave covid -19
The second wave covid -19
 
COVID 19 meta analysis - DIG- April-28-2020
COVID 19 meta analysis - DIG- April-28-2020COVID 19 meta analysis - DIG- April-28-2020
COVID 19 meta analysis - DIG- April-28-2020
 
Case study of covid 19.pdf by HARSHITHA BHARADWAJ
Case study of covid 19.pdf by HARSHITHA BHARADWAJCase study of covid 19.pdf by HARSHITHA BHARADWAJ
Case study of covid 19.pdf by HARSHITHA BHARADWAJ
 
Abstract congress covid 19.docx30
Abstract congress covid 19.docx30Abstract congress covid 19.docx30
Abstract congress covid 19.docx30
 
covoid 19.pptx
covoid 19.pptxcovoid 19.pptx
covoid 19.pptx
 
Corona Virus
Corona VirusCorona Virus
Corona Virus
 
Similarities and Differences between the New Coronavirus Infectious 2019 COVI...
Similarities and Differences between the New Coronavirus Infectious 2019 COVI...Similarities and Differences between the New Coronavirus Infectious 2019 COVI...
Similarities and Differences between the New Coronavirus Infectious 2019 COVI...
 

Recently uploaded

Preventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & TreatmentPreventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & Treatment
LAB Sports Therapy
 
Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
Nguyễn Thị Vân Anh
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
ranishasharma67
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Dr. David Greene Arizona
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
Aboud Health Group
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
o6ov5dqmf
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
ranishasharma67
 
Overcome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptxOvercome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptx
renewlifehypnosis
 
Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤
Dehradun ❤CALL Girls  8901183002 ❤ℂall  Girls IN Dehradun ESCORT SERVICE❤Dehradun ❤CALL Girls  8901183002 ❤ℂall  Girls IN Dehradun ESCORT SERVICE❤
Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤
aunty1x2
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
Ahmed Elmi
 
What Are Homeopathic Treatments for Migraines.pdf
What Are Homeopathic Treatments for Migraines.pdfWhat Are Homeopathic Treatments for Migraines.pdf
What Are Homeopathic Treatments for Migraines.pdf
Dharma Homoeopathy
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
pubrica101
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
pchutichetpong
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
priyabhojwani1200
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
Rommel Luis III Israel
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
SasikiranMarri
 
Deepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptxDeepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptx
mahalsuraj389
 

Recently uploaded (20)

Preventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & TreatmentPreventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & Treatment
 
Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
 
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
一比一原版纽约大学毕业证(NYU毕业证)成绩单留信认证
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
 
Overcome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptxOvercome Your Phobias with Hypnotherapy.pptx
Overcome Your Phobias with Hypnotherapy.pptx
 
Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤
Dehradun ❤CALL Girls  8901183002 ❤ℂall  Girls IN Dehradun ESCORT SERVICE❤Dehradun ❤CALL Girls  8901183002 ❤ℂall  Girls IN Dehradun ESCORT SERVICE❤
Dehradun ❤CALL Girls 8901183002 ❤ℂall Girls IN Dehradun ESCORT SERVICE❤
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 
What Are Homeopathic Treatments for Migraines.pdf
What Are Homeopathic Treatments for Migraines.pdfWhat Are Homeopathic Treatments for Migraines.pdf
What Are Homeopathic Treatments for Migraines.pdf
 
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptxBOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
BOWEL ELIMINATION BY ANUSHRI SRIVASTAVA.pptx
 
How many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdfHow many patients does case series should have In comparison to case reports.pdf
How many patients does case series should have In comparison to case reports.pdf
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
 
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptxGLOBAL WARMING BY PRIYA BHOJWANI @..pptx
GLOBAL WARMING BY PRIYA BHOJWANI @..pptx
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
 
Deepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptxDeepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptx
 

Analytics on covid 19

  • 1. ANALYTICS OF COVID19 ON WORLD & INDIA Dr. Abhishek Kumar M.B.B.S.,M.D.E.M.S.,A.F.I.H.,C.C.D.M.,D. Diabetology
  • 2. What is the need of analytic study?
  • 3. What is the need of analytic study?  The aim is to answer several open questions: 1. How does COVID-19 spread around the world? 2. What is its impact in terms of confirmed and death cases at the continent, region, and country levels? 3. How does its severity compare with other epidemic outbreaks, including Ebola 2014,MERS 2012, and SARS 2003? 4. Is there a correlation between the number of confirmed cases and death cases? This presentation presents a comprehensive analytics visualization to address the questions mentioned above.
  • 4. How does COVID-19 spread around the world :-  The Coronavirus (COVID-19) outbreak nowadays represents the most critical event worldwide.  It has been declared by the World Health Organization (WHO) as a Global Public Health Emergency  By the end of January 2020, and then as a Global Pandemic in March 2020.  The virus has begun on from Wuhan district in China , where the first confirmed case was reported to have happened on November 17, 2020 .  Initially, the confirmed cases in China were continually increasing.  On January 31, the total infections reached a bit less than 10000 confirmed cases, with214 recovered and 213 reported deaths (2% death rate, and similar for recovery).
  • 5.  One of the most dangerous aspects of the Coronavirus is that it has an incubation period of 2-14 days, during which the patient transmits the virus without having any symptoms.  All these circumstances have favored the exponential growth of the infection leading to a world health emergency crisis.  A total of 173 countries are reported to have confirmed cases with different gravity, while only 60 countries had confirmed cases at the end of February 2020, and only 25 countries at the end of January 2020.  This means that the increase rate was between 2.4 to 2.9 each month.  As a consequence, after only two months from the official declaration of COVID-19 as Global Public Health Emergency, and despite the numerous exceptional preventive measures that every country has taken to avoid the outbreak, the virus has contaminated almost all the world countries.  We compare the impact of the COVID-19 virus with the previous and recent epidemic diseases that have emerged in the last 20 years, namely Ebola 2014, Middle East Respiratory Syndrome (MERS 2012), and Severe Acute Respiratory Syndrome (SARS 2003) outbreaks.
  • 6. World wide spread of COVID-19. Observed from the figure that the outbreak pick growth started towards the end of February, which is almost four weeks since the disease was declared as a Global Public Health Emergency.
  • 7. WORLD COVID-19 DATA dated 23/4/20 TOTAL COVID CASES  Coronavirus Cases: 2,638,909  Deaths:184,249  Recovered:722,055 ACTIVE CASES:1,732,605  Currently Infected Patients  1,674,327 (97%)in Mild Condition  58,278 (3%)Serious or Critical CLOSED CASES: 906,304  Cases which had an outcome:  722,055 (80%)Recovered / Discharged  184,249 (20%)Deaths
  • 8. How does COVID-19 evolve and its impact:- COVID-19 DATA FOR LAST 3 MONTHS : Cumulative Cases/Day January 2020 February 2020 March 2020 Confirmed Case Rate 1071 2730 16679 Death Cases 22 103 792 Recovered Cases 19 1373 2906 Active Cases 1029 1252 12890  The global cumulative confirmed case rates are 2.54 times higher in February 2020, and 15.67 times higher in March 2020, as compared to the confirmed case rate of January 2020. COVID-19 Dashboard 1: The four figures in the first row presents the cumulative confirmed, recovered, death and active cases from January 22,2020 to March 27, 2020.
  • 9. INTERPRETATION:  The global cumulative recovered case rates are 72.26 times higher in February 2020, and 152 times higher in March 2020, as compared to the recovered case rate of January 2020. This indicates the reduction in the severe and increasing fatality impact of the COVID-19. This is a good indication that, with the increase in the number of cases, there is a better understanding of the disease and containment.  The global cumulative death case rates are 4.68 times higher in February 2020, and 36 times higher in March 2020, as compared to the death case rate of January2020. This indicates the severe and increasing fatality impact of the COVID- 19. Death rates in February were stationary at an average of 92 deaths per day. However, in March 2020, the death rates had a factor of 108.  Comparing the trend death and the trend of recovered cases, it can be observed that the ratio of recovered to death rates, was 0.86 (19/22) in January 2020,meaning that the death rate was a bit higher .However, in February 2020, the ratio of recovered to death rates increases to 13.33 (1373/103) and reaches 3.66 (2906/792) in March 2020. The general trend is that the disease is being more controlled in terms of fatality rates due to increasing emergency procedures that the different countries have implemented.
  • 10.  It has been observe that in the top-10 countries, there are six countries are from Europe (i.e., Italy, Spain, Germany, France, United Kingdom, and Switzerland), three from Asia (China, Iran and South Korea), and the United States of America, which recently become top-1 in terms of the number of infections.  Nonetheless, the highest death rate is in Italy, with more than 9000 death cases reported, because Italy has been severely affected by the virus well before the USA, since the end of February. However, the USA is currently having a death rate of 39 deaths per day, whereas it has 0 deaths in February 2020.  Based on the data collected there is a strongly believed that the COVID-19 takes almost one month to transit from one continent to another in the direction from the East to the West since the pick was in China at the end of January, then it was in Italy (South of Europe) at the end of February, and it reached the USA at the end of March, where the pick of infection are in New York located at the Eastern side of the USA.  The Eastern side of the USA, and mainly New York, are the most affected considering that it is closer to Europe. If the trend is the same, it will be expected that the West side of the USA will reach its pick by the end of April 2020.
  • 11.
  • 12. How does COVID-19 compare to other epidemics?  It is visually apparent that COVID-19 is the largest outbreak to a considerable extent, followed by SAR 2003, then Ebola 2012, and finally, MERS 2001.  In what concerns the number of infected countries, COVID-19 has reached 177 countries, then SARS 2003 reached 36 countries, then MERS 2012 has affected 27 countries, and Ebola 2014 was spread in 10 countries. The severity and acuteness of COVID-19 are unprecedented.  Ebola 2014 has spanned over a significant period from August 2014 until March 2016, it reached only 15249 confirmed cases. Thus it had an infection rate minimal as compared to the two other diseases. Most of the confirmed cases were concentrated in the Western coast of Africa, where the disease has emerged.  SARS 2003 had a lifetime of five months from March 2003 until July 2003 and reached 8434 confirmed cases with an average of 1686 cases per month, and a pick rate in April 2003, one month after the outbreak.  It can be observed that COVID-19 is considered as a more acute specie of SARS 2003, as they both share some common features, including: (1) both have started from China, (2)they belong to the same family of Coronavirus syndrome affecting the respiratory system, (3) they have the highest contamination rate as compared to other epidemics.  Based on these observations, it seems that the COVID-19 containment will take a more extended period for its complete containment as compared to SARS 2003.
  • 13.
  • 14.
  • 15. Impact in terms of confirmed and death cases at the continent, region, and country levels:- We can conclude that theCOVID-19 is exceptionally more aggressive in terms of confirmed cases with more than 90% of the share of the heat map, where it is at around 80% concerning the fatality impact. The remaining 10% of confirmed cases and 20% of death cases are shared between Ebola 2014 and SARS 2003.  At continent-level, Europe is the most affected with COVID-19 with 51.64% of confirmed cases, then Asia with 23.92%, and the Americas with 19.02%. The impact of Ebola on Africa is only 2.46%, and the impact of SARS 2003 on Asia is only 1.26 %.  At region-level, the Southern Europe region has 25.94% of confirmed cases, followed by Western Europe Asia 19.8%, then Northern America 17.19%, and Eastern Asia with 15%. The impact of Ebola 2014 on Western Africa is valued to 2.46%, and the impact of SARS Eastern Asia is only 1.26%.
  • 16. At the country-level, The USA has the most significant share of confirmed cases (as of March 27, 2020) with 16.43%, followed by Italy 13.98%, then China 13.15%. We can also observe that the number of confirmed cases of Ebola 2014 in Sierra Leon is similar to the COVID-19 spread in South Korea and countries in the West of Europe, namely, Netherlands, Belgium, and Austria.  Regarding the death cases’ impact, it is different from the confirmed cases. At continent-level, the highest death impact is in Europe with 56.26%, then Asia with 18.56% with COVID-19, which is of the same magnitude as the fatality of Ebola 2014 in Africa.  The highest average of confirmed cases per continent is in Europe, with 4992 deaths of COVID-19, and the second-highest average confirmed cases per continent is 1906 deaths in Africa with Ebola 2014. MERS and SARS have the same average confirmed cases. Regarding the average deaths per continent, Ebola 2014 comes in the first place with 947 deaths per country in Africa on average followed by COVID-19, with 296 deaths in each European country on average. SARS 2003 only affected 55 deaths per country in Asia on average. MEDIAN AGE PER CONTINENT
  • 17. INDIA COVID-19 DATA dated 23/4/20  Confirmed: 21,455  Active: 16,391  Recovered: 4,382  Deceased: 682 The first case in India was reported on 30th January 2020. Also, a single case can infect 1.5 more individuals of the population. Epidemic doubling time is estimated to be around 4.1 days
  • 18. State/UT Confirmed Active Recovered Deceased Maharashtra 5,649 4,591 789 269 Gujarat 2,407 2,125 179 103 Delhi 2,248 1,476 724 48 Rajasthan 1,935 1,564 344 27 Tamil Nadu 1,629 949 662 18 Madhya Pradesh 1,587 1,355 152 80 Uttar Pradesh 1,449 1,255 173 21 Telangana 943 725 194 24 Andhra Pradesh 813 669 120 24 West Bengal 456 362 679 15 Kerala 437 127 308 2 Karnataka 427 279 131 17 Jammu and Kashmir 407 310 92 5 Punjab 278 209 53 16 Haryana 264 103 158 3 Bihar 143 99 42 2 Odisha 83 50 32 1 Jharkhand 49 38 48 13 Uttarakhand 46 23 23 - Himachal Pradesh 39 21 16 2 Chhattisgarh 36 8 28 - Assam 35 15 19 1 Chandigarh 27 13 14 - Andaman and Nicobar Islands 18 7 11 - Ladakh 18 2 216 - Meghalaya 12 11 - 1 Goa 7 - 7 - Puducherry 7 3 4 - Manipur 2 - 2 - Tripura 2 1 1 - Arunachal Pradesh 1 - 1 - Mizoram 1 1 - - Total 8321,455 16,391 124,382 1682
  • 19. The COVID19 Hot-Spot Map of India]
  • 20. Challenges in front of India: • AVERAGE HEALTH CARE SYSYTEM • ILLITERACY • POVERTY • IGNORANCE • UNEMPLOYEMENT • MIGRATION
  • 21. Age Wise COVID-19 Patients: We can notice that the 21-60 years group constitute for 77% of the total patients. 0-30 years constitutes to 30% of the total patients and this is significant as this group falls into a “super-spreader” category.
  • 22. Individual States vs National average of age-wise break up of COVID19 patients Delhi has a very high proportion of patients in the 21-30 years age bucket. Uttar Pradesh has a high proportion of patients in the 31-40 years age bucket.
  • 23. In Rajasthan, it is a case of the elderly getting infected more as they have a lot of patients in the 61-70 years age bracket. Telangana like Delhi has more patients in the 21-30 years age bracket. For the 21-30 years age bracket, more social media messaging would help.
  • 24. RECOVERY PERIOD OF PATIENTS Illustrated 36% of patients get discharged within 10 days, 43% within 20 days and the rest within a month from being confirmed positive. This data can help governments to better equip hospital beds or ventilators IF we see high exponential rise of cases in India. It can also be used to assess the severity of the cases and the effects of the treatment meted out to patients.
  • 25. Sex wise COVID-19 Patients: Men do continue to lead the charts. This is in line with the global numbers, where 2/3rd of the infected are men. In India, 69% of the infections involve men and the rest are female.
  • 26. IMPORTED VS LOCAL As of now, we have 73% local cases and 27% imported cases. The biggest contributor to the local cases was of course the #Tablighi Jamaat cluster.
  • 27. Breakup of foreigners tested +ve in India We have a host of Italian and Indonesian citizens who has tested positive in India along with UK citizens. The Jamaat cluster gave rise to a lot of Indonesian, Malaysian and Thai nationals testing positive for COVID-19.
  • 28. What’s in future India?  The coronavirus pandemic in India may peak in early to mid-May, according to projections in a study conducted by global consulting firm Protiviti and Times Network. The study predicts the number of cases will range from 30,000 to a worst-case scenario of about 286,000. About 30% of the affected people may require intensive care facilities.  Susceptible Exposed Infected Recovered (SEIR)model suggests the pandemic may continue on a nationwide scale until August end. Some states may come out of the crisis by late May or early June while states with a higher number of infected people may take up to a month longer.  The Covid-19 pandemic is causing deep economic harm and could reverse the gains made in the industrial economy over many decades. There is a need to render immediate and sizable support to industry to protect people, jobs and enterprises."
  • 29.  Oxford University will start human testing with a Covid-19 vaccine they developed from Thursday, the UK government said in a coronavirus press conference.  The Oxford team – led by Professor Sarah Gilbert, is testing ChAdOx1 nCoV-19, a candidate based on a chimpanzee adenovirus modified to include the spike or ‘S’ protein on the surface of SARS-CoV-2, the virus that causes Covid-19.